Content area

Abstract

ABSTRACT

Background:

Lonicerin (LON) has been identified to have different biological properties, such as anticancer, anti‐inflammatory, immunomodulatory, antibacterial, antimicrobial, and neuroprotective. This study aims to assess the sedative effect of LON in Swiss albino mice, which is yet to be discovered.

Materials and Methods:

Mice were treated with two different doses of LON (5 and 10 mg/kg) and 2 mg/kg of diazepam (DZP), which is the referral GABAergic medication, and the latency time and sleeping duration of animals were observed. A computational study was also conducted to evaluate the docking scores and display the binding sites of LON and receptor (GABAA α1 and β2 subunits). The study also investigated the pharmacokinetics and drug‐likeness properties of LON along with toxicological analysis by using SwissADME and Protox‐3 software, respectively.

Results:

Findings revealed that the higher concentration of LON reduced the latency (9.86 ± 1.44 min) and increased the sleep duration (191.29 ± 7.43 min) compared to the lower concentration. Besides, the combination group of LON and DZP showed the lowest latency (6.17 ± 0.82 min) and highest sleeping time (219.00 ± 6.39 min). In the in silico study, LON exhibited a strong docking score (−8.1 kcal/mol) with the macromolecules, which is closer to the binding affinity of DZP (–8.3 kcal/mol), indicating that LON could show strong sedative activity by binding with the GABAA receptor. Computational toxicity analysis revealed that LON is non‐hepatotoxic, non‐neurotoxic, noncarcinogenic, noncytotoxic, non‐ecotoxic, and non‐mutagenic.

Conclusion:

Therefore, LON may be effective for the treatment of insomnia in the near future.

Details

1009240
Location
Title
Assessment of Sedative Activity of Lonicerin: In Vivo Approach With Pharmacokinetics and Molecular Docking
Author
Eity, Tanzila Akter 1   VIAFID ORCID Logo  ; Bhuia, Md. Shimul 2   VIAFID ORCID Logo  ; Chowdhury, Raihan 2   VIAFID ORCID Logo  ; Sheikh, Salehin 2   VIAFID ORCID Logo  ; Ansari, Siddique Akber 3 ; Ahammed, Nowreen Tabassum 4 ; Kamli, Hossam 5 ; Islam, Muhammad Torequl 6   VIAFID ORCID Logo 

 Department of Biotechnology and Genetic Engineering, Gopalganj Science and Technology University, Gopalganj, Bangladesh, Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Bangladesh 
 Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh, Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Bangladesh 
 Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia 
 Department of Biology, Touro University, New York City, New York, USA 
 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia 
 Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh, Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Bangladesh, Pharmacy Discipline, Khulna University, Khulna, Bangladesh 
Publication title
Brain and Behavior; Los Angeles
Volume
15
Issue
5
Publication year
2025
Publication date
May 1, 2025
Section
ORIGINAL ARTICLE
Publisher
John Wiley & Sons, Inc.
Place of publication
Los Angeles
Country of publication
United States
Publication subject
e-ISSN
21623279
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2025-05-05
Milestone dates
2025-04-15 (manuscriptRevised); 2025-05-05 (publishedOnlineFinalForm); 2024-11-04 (manuscriptReceived); 2025-04-17 (manuscriptAccepted)
Publication history
 
 
   First posting date
05 May 2025
ProQuest document ID
3210269073
Document URL
https://www.proquest.com/scholarly-journals/assessment-sedative-activity-lonicerin-vivo/docview/3210269073/se-2?accountid=208611
Copyright
© 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-05-27
Database
ProQuest One Academic